Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly

被引:12
|
作者
Starr, JM [1 ]
Impallomeni, M [1 ]
机构
[1] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, LONDON, ENGLAND
关键词
C difficile; cephalosporins; aging;
D O I
10.1016/S0753-3322(97)87728-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clostridium difficile diarrhoea is an increasingly important nosocomial infection. Clostridium difficile infection is associated with antibiotic use. The elderly are at greatest risk. We reported an outbreak associated with the use of cefotaxime, a third-generation cephalosporin. We review the extent of this association, putative causal mechanisms and suggest an integrated approach to the control of C difficile infection which focusses on both limiting environmental contamination and reducing patient susceptibility. Future developments are also considered, especially the potential for vaccination.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 50 条
  • [1] Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment - Reply
    Impallomeni, M
    Starr, J
    Rogers, T
    BRITISH MEDICAL JOURNAL, 1996, 312 (7033): : 778 - 778
  • [2] Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam
    Settle, CD
    Wilcox, MH
    Fawley, WN
    Corrado, OJ
    Hawkey, PM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (12) : 1217 - 1223
  • [3] Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment - Mortality due to C-difficile colitis in elderly people has been underestimated
    Lesna, M
    Parham, DM
    BRITISH MEDICAL JOURNAL, 1996, 312 (7033): : 778 - 778
  • [4] Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment - Cefotaxime compares favourably with other third generation cephalosporins
    Rothschild, E
    Rauss, A
    Danan, G
    BRITISH MEDICAL JOURNAL, 1996, 312 (7033): : 778 - 778
  • [5] INCREASED RISK OF DIARRHEA CAUSED BY CLOSTRIDIUM-DIFFICILE IN ELDERLY PATIENTS RECEIVING CEFOTAXIME
    IMPALLOMENI, M
    GALLETLY, NP
    WORT, SJ
    STARR, JM
    ROGERS, TR
    BRITISH MEDICAL JOURNAL, 1995, 311 (7016): : 1345 - 1346
  • [6] Symptomless colonisation by Clostridium difficile and risk of diarrhoea
    Engels, EA
    Lau, J
    LANCET, 1998, 351 (9117): : 1733 - 1733
  • [7] Clarithromycin and risk of Clostridium difficile-associated diarrhoea
    Wilcox, MH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (03) : 358 - 359
  • [8] Diarrhoea associated to Clostridium difficile
    Puente, RZ
    Farinas, MC
    Palomo, JDG
    Balbin, JA
    MEDICINA CLINICA, 1998, 110 (09): : 359 - 359
  • [9] Diarrhoea by Clostridium difficile toxin
    Prada, J. L.
    Moreno, F.
    De La Torre, J.
    Del Arco, A.
    Aguilar, J.
    Ruiz, J. D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S658 - S658
  • [10] Recurrent Clostridium difficile diarrhoea
    Kyne, L
    Kelly, CP
    GUT, 2001, 49 (01) : 152 - 153